Tetrylammonium

Tetrylammonium

SCHEMBL621848

CC[N+](CC)(CC)CC.O=S(=O)([O-])[O-].[H+]

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Tetrylammonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.53
NFKB1 P19838 1/20 0.53
KCNA1 Q09470 1/20 0.53
KDM4E B2RXH2 1/20 0.50
PMP22 Q01453 1/20 0.50
ATM Q13315 1/20 0.50
BBOX1 O75936 2/20 0.37
TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrylammonium SCHEMBL36703 0.97 TSHR (0.57) TSHRNFKB1KCNA1KDM4EPMP22
Tetrylammonium SCHEMBL28602156 0.93 TSHR (0.53) TSHRNFKB1KCNA1KDM4EPMP22
Tetrylammonium SCHEMBL3643964 0.93 TSHR (0.53) TSHRNFKB1KCNA1KDM4EPMP22
Tetrylammonium SCHEMBL7638063 0.90 TSHR (0.50) TSHRNFKB1KCNA1KDM4EPMP22
Tetrylammonium SCHEMBL5571612 0.88 TSHR (0.47) TSHRNFKB1KCNA1KDM4EPMP22
Tetrylammonium SCHEMBL331443 0.87 TSHR (0.53) TSHRNFKB1KCNA1KDM4EPMP22
Tetrylammonium SCHEMBL331297 0.87 TSHR (0.53) TSHRNFKB1KCNA1KDM4EPMP22
Tetrylammonium SCHEMBL36705 0.84 TSHR (0.50) TSHRNFKB1KCNA1KDM4EPMP22
Tetrylammonium SCHEMBL14118730 0.84 TSHR (0.50) TSHRNFKB1KCNA1KDM4EPMP22
Tetrylammonium SCHEMBL36660 0.84 TSHR (0.50) TSHRNFKB1KCNA1KDM4EPMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 169 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3904451-B1 POLYVINYLIDENE FLUORIDE RESIN COMPOSITION AND MOLDED BODY KUREHA CORP (JP) 2025-08-27 EP claimed
US-20250171409-A1 PROCESS OF PREPARATION OF INDOXACARB AND ITS INTERMEDIATES ADAMA MAKHTESHIM LTD. (IL) 2025-05-29 US claimed
US-20250043039-A1 HALOGEN RECOVERY WITH OXIDANT AND PHASE TRANSFER CATALYST IN A PROCESS FOR HALOGENATING UNSATURATED ISOOLEFIN COPOLYMER ARLANXEO SINGAPORE PTE. LTD. (SG) 2025-02-06 US claimed
EP-4460499-A1 PROCESS OF PREPARATION OF INDOXACARB AND ITS INTERMEDIATES ADAMA MAKHTESHIM LTD. (IL) 2024-11-13 EP claimed
EP-4448595-A1 HALOGEN RECOVERY WITH OXIDANT AND PHASE TRANSFER CATALYST IN A PROCESS FOR HALOGENATING UNSATURATED ISOOLEFIN COPOLYMER Arlanxeo Singapore Pte. Ltd. (SG) 2024-10-23 EP claimed
CN-114195140-B Method for preparing controllable graphene by electrode and magnetic field regulation ion intercalation 江苏大学 2024-02-09 CN claimed
CN-117209330-A Special intelligent controlled-release fertilizer for corn and preparation method thereof 山东农业大学 2023-12-12 CN claimed
US-11834572-B2 Polyvinylidene fluoride resin composition and molded article KUREHA CORPORATION (JP) 2023-12-05 US claimed
WO-2023131943-A1 PROCESS OF PREPARATION OF INDOXACARB AND ITS INTERMEDIATES ADAMA MAKHTESHIM LTD. (IL) 2023-07-13 WO claimed
WO-2023108259-A1 HALOGEN RECOVERY WITH OXIDANT AND PHASE TRANSFER CATALYST IN A PROCESS FOR HALOGENATING UNSATURATED ISOOLEFIN COPOLYMER ARLANXEO SINGAPORE PTE. LTD. (SG) 2023-06-22 WO claimed
CN-111560117-A Preparation method of siloxane copolycarbonate 万华化学集团股份有限公司 2020-08-21 CN claimed
CN-111470499-A Method for electrochemically preparing graphene 中钢集团南京新材料研究院有限公司 2020-07-31 CN claimed
CN-111196874-A Polyester block copolycarbonate and preparation method thereof 万华化学集团股份有限公司 2020-05-26 CN claimed
CN-111187403-A Siloxane copolycarbonate and preparation method thereof 万华化学集团股份有限公司 2020-05-22 CN claimed
US-7541312-B2 Porous carbons from carbohydrates TDA RESEARCH, INC. (US) 2009-06-02 US claimed
EP-1725497-A4 POROUS CARBONS FROM CARBOHYDRATES TDA RESEARCH INC (US) 2008-11-05 EP claimed
EP-1725497-A2 POROUS CARBONS FROM CARBOHYDRATES TDA RESEARCH, INC. (US) 2006-11-29 EP claimed
WO-2005089145-A2 POROUS CARBONS FROM CARBOHYDRATES TDA RESEARCH, INC. (US) 2005-09-29 WO claimed
US-20050207962-A1 Porous carbons from carbohydrates TDA RESEARCH, INC. (US) 2005-09-22 US claimed
US-20050208248-A1 Automotive fuel hose and method for producing the same TOKAI RUBBER INDUSTRIES, LTD. (JP) 2005-09-22 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250171409-A1 PROCESS OF PREPARATION OF INDOXACARB AND ITS INTERMEDIATES DDT, IDO2, INSR TSHR 407/4885NFKB1 1530/4885KCNA1 721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.